Argus Cuts CVS Health (NYSE:CVS) Price Target to $90.00

CVS Health (NYSE:CVS) had its price objective decreased by Argus from $91.00 to $90.00 in a research note issued to investors on Wednesday, Marketbeat reports. Argus currently has a buy rating on the pharmacy operator’s stock.

CVS has been the subject of several other research reports. Raymond James Financial increased their price objective on CVS Health from $75.00 to $90.00 in a report on Friday, October 31st. Morgan Stanley increased their price target on shares of CVS Health from $89.00 to $93.00 and gave the company an “overweight” rating in a research note on Wednesday, December 10th. The Goldman Sachs Group boosted their price objective on shares of CVS Health from $93.00 to $95.00 and gave the stock a “buy” rating in a research note on Wednesday, December 10th. Weiss Ratings reiterated a “hold (c-)” rating on shares of CVS Health in a research note on Monday, December 29th. Finally, Wolfe Research boosted their price target on CVS Health from $85.00 to $100.00 and gave the stock an “outperform” rating in a research report on Monday, December 8th. Nineteen investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $94.82.

CVS Health Price Performance

Shares of NYSE CVS opened at $74.51 on Wednesday. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.63. The business has a 50-day moving average of $78.90 and a 200-day moving average of $75.08. The stock has a market capitalization of $94.59 billion, a price-to-earnings ratio of 196.09, a PEG ratio of 0.68 and a beta of 0.48. CVS Health has a fifty-two week low of $53.36 and a fifty-two week high of $85.15.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, beating the consensus estimate of $1.36 by $0.24. The firm had revenue of $102.87 billion during the quarter, compared to analysts’ expectations of $98.85 billion. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The business’s quarterly revenue was up 7.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.09 earnings per share. As a group, sell-side analysts predict that CVS Health will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, February 2nd. Investors of record on Thursday, January 22nd will be paid a $0.665 dividend. The ex-dividend date is Thursday, January 22nd. This represents a $2.66 annualized dividend and a yield of 3.6%. CVS Health’s payout ratio is 700.00%.

Institutional Investors Weigh In On CVS Health

Institutional investors have recently modified their holdings of the business. Avion Wealth raised its stake in CVS Health by 99.0% in the 2nd quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 189 shares in the last quarter. Harbor Capital Advisors Inc. raised its position in shares of CVS Health by 72.1% in the third quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock valued at $26,000 after buying an additional 142 shares in the last quarter. Caitong International Asset Management Co. Ltd grew its position in CVS Health by 407.2% during the third quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock worth $26,000 after buying an additional 281 shares in the last quarter. Corundum Trust Company INC bought a new position in CVS Health during the 3rd quarter worth $29,000. Finally, Ares Financial Consulting LLC acquired a new position in CVS Health in the 4th quarter valued at $29,000. Institutional investors own 80.66% of the company’s stock.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.